Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
J Mol Biol ; 434(5): 167403, 2022 03 15.
Artículo en Inglés | MEDLINE | ID: covidwho-1611867

RESUMEN

COVID-19 caused by SARS-CoV-2 is the latest pandemic which has thrown the world into an unprecedented social and economic uncertainties along with huge loss to humanity. Identification of the host factors regulating the replication of SARS-CoV-2 in human host may help in the development of novel anti-viral therapies to combat the viral infection and spread. Recently, some research groups used genome-wide CRISPR/Cas screening to identify the host factors critical for the SARS-CoV-2 replication and infection. A comparative analysis of these significant host factors (p < 0.05) identified fifteen proteins common in these studies. Apart from ACE2 (receptor for SARS-CoV-2 attachment), other common host factors were CSNK2B, GDI2, SLC35B2, DDX51, VPS26A, ARPP-19, C1QTNF7, ALG6, LIMA1, COG3, COG8, BCOR, LRRN2 and TLR9. Additionally, viral interactome of these host factors revealed that many of them were associated with several SARS-CoV-2 proteins as well. Interestingly, some of these host factors have already been shown to be critical for the pathogenesis of other viruses suggesting their crucial role in virus-host interactions. Here, we review the functions of these host factors and their role in other diseases with special emphasis on viral diseases.


Asunto(s)
COVID-19/virología , Interacciones Microbiota-Huesped , Factores Celulares Derivados del Huésped/metabolismo , Pandemias , SARS-CoV-2/fisiología , COVID-19/epidemiología , Repeticiones Palindrómicas Cortas Agrupadas y Regularmente Espaciadas , Factores Celulares Derivados del Huésped/genética , Humanos , SARS-CoV-2/genética
2.
Front Immunol ; 11: 565521, 2020.
Artículo en Inglés | MEDLINE | ID: covidwho-1389164

RESUMEN

Neurological disorders caused by neuroviral infections are an obvious pathogenic manifestation. However, non-neurotropic viruses or peripheral viral infections pose a considerable challenge as their neuropathological manifestations do not emerge because of primary infection. Their secondary or bystander pathologies develop much later, like a syndrome, during and after the recovery of patients from the primary disease. Massive inflammation caused by peripheral viral infections can trigger multiple neurological anomalies. These neurological damages may range from a general cognitive and motor dysfunction up to a wide spectrum of CNS anomalies, such as Acute Necrotizing Hemorrhagic Encephalopathy, Guillain-Barré syndrome, Encephalitis, Meningitis, anxiety, and other audio-visual disabilities. Peripheral viruses like Measles virus, Enteroviruses, Influenza viruses (HIN1 series), SARS-CoV-1, MERS-CoV, and, recently, SARS-CoV-2 are reported to cause various neurological manifestations in patients and are proven to be neuropathogenic even in cellular and animal model systems. This review presents a comprehensive picture of CNS susceptibilities toward these peripheral viral infections and explains some common underlying themes of their neuropathology in the human brain.


Asunto(s)
Betacoronavirus/inmunología , Infecciones por Coronavirus/complicaciones , Infecciones por Coronavirus/inmunología , Coronavirus del Síndrome Respiratorio de Oriente Medio/inmunología , Inflamación Neurogénica/complicaciones , Inflamación Neurogénica/inmunología , Neumonía Viral/complicaciones , Neumonía Viral/inmunología , Síndrome Respiratorio Agudo Grave/complicaciones , Coronavirus Relacionado al Síndrome Respiratorio Agudo Severo/inmunología , Animales , Barrera Hematoencefálica/inmunología , Barrera Hematoencefálica/virología , COVID-19 , Infecciones por Coronavirus/virología , Citocinas/sangre , Modelos Animales de Enfermedad , Humanos , Microglía/inmunología , Microglía/virología , Inflamación Neurogénica/virología , Pandemias , Neumonía Viral/virología , SARS-CoV-2 , Síndrome Respiratorio Agudo Grave/inmunología , Síndrome Respiratorio Agudo Grave/virología
3.
Front Immunol ; 12: 656700, 2021.
Artículo en Inglés | MEDLINE | ID: covidwho-1211815

RESUMEN

SARS-CoV-2, the novel coronavirus infection has consistently shown an association with neurological anomalies in patients, in addition to its usual respiratory distress syndrome. Multi-organ dysfunctions including neurological sequelae during COVID-19 persist even after declining viral load. We propose that SARS-CoV-2 gene product, Spike, is able to modify the host exosomal cargo, which gets transported to distant uninfected tissues and organs and can initiate a catastrophic immune cascade within Central Nervous System (CNS). SARS-CoV-2 Spike transfected cells release a significant amount of exosomes loaded with microRNAs such as miR-148a and miR-590. microRNAs gets internalized by human microglia and suppress target gene expression of USP33 (Ubiquitin Specific peptidase 33) and downstream IRF9 levels. Cellular levels of USP33 regulate the turnover time of IRF9 via deubiquitylation. Our results also demonstrate that absorption of modified exosomes effectively regulate the major pro-inflammatory gene expression profile of TNFα, NF-κB and IFN-ß. These results uncover a bystander pathway of SARS-CoV-2 mediated CNS damage through hyperactivation of human microglia. Our results also attempt to explain the extra-pulmonary dysfunctions observed in COVID-19 cases when active replication of virus is not supported. Since Spike gene and mRNAs have been extensively picked up for vaccine development; the knowledge of host immune response against spike gene and protein holds a great significance. Our study therefore provides novel and relevant insights regarding the impact of Spike gene on shuttling of host microRNAs via exosomes to trigger the neuroinflammation.


Asunto(s)
COVID-19/metabolismo , Exosomas/metabolismo , Subunidad gamma del Factor 3 de Genes Estimulados por el Interferón/metabolismo , MicroARNs/metabolismo , Microglía/metabolismo , SARS-CoV-2/metabolismo , Glicoproteína de la Espiga del Coronavirus/metabolismo , Ubiquitina Tiolesterasa/metabolismo , COVID-19/genética , COVID-19/fisiopatología , COVID-19/virología , Línea Celular , Sistema Nervioso Central/inmunología , Sistema Nervioso Central/fisiopatología , Sistema Nervioso Central/virología , Endopeptidasas/metabolismo , Exosomas/genética , Exosomas/patología , Humanos , Inflamación/inmunología , Inflamación/virología , Interferón beta/metabolismo , MicroARNs/genética , Microglía/patología , FN-kappa B/metabolismo , Estabilidad Proteica , Factor de Necrosis Tumoral alfa/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA